EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluvastatin Converts Human Macrophages into Foam Cells with Increased Inflammatory Response to Inactivated Mycobacterium tuberculosis H37Ra

María Teresa Montero-Vega, Joaquín Matilla iD, Eulalia Bazán, Diana Reimers, Ana De Andrés-Martín, Rafael Gonzalo-Gobernado iD, Carlos Correa, Francisco Urbano, Diego Gómez-Coronado iD

Cells · 2024

DOI: 10.3390/cells13060536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von María Teresa Montero-Vega und 8 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Bioquímica-Investigación, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Tuberculosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo de Investigación Sanitaria, Instituto Ramón y Cajal de Investigación Sanitaria, Fondo de Investigación Sanitaria, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholesterol biosynthesis inhibitors (statins) protect hypercholesterolemic patients against developing active tuberculosis, suggesting that these drugs could help the host to control the pathogen at the initial stages of the disease. This work studies the effect of fluvastatin on the early response of healthy peripheral blood mononuclear cells (PBMCs) to inactivated Mycobacterium tuberculosis (Mtb) H37Ra. We found that in fluvastatin-treated PBMCs, most monocytes/macrophages became foamy cells that overproduced NLRP3 inflammasome components in the absence of immune stimulation, evidencing important cholesterol metabolism/immunity connections. When both fluvastatin-treated and untreated PBMCs were exposed to Mtb H37Ra, a small subset of macrophages captured large amounts of bacilli and died, concentrating the bacteria in necrotic areas. In fluvastatin-untreated cultures, most of the remaining macrophages became epithelioid cells that isolated these areas of cell death in granulomatous structures that barely produced IFNγ. By contrast, in fluvastatin-treated cultures, foamy macrophages surrounded the accumulated bacteria, degraded them, markedly activated caspase-1 and elicited a potent IFNγ/cytotoxic response. In rabbits immunized with the same bacteria, fluvastatin increased the tuberculin test response. We conclude that statins may enhance macrophage efficacy to control Mtb, with the help of adaptive immunity, offering a promising tool in the design of alternative therapies to fight tuberculosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisHydroxymethylglutaryl-CoA Reductase InhibitorsTuberculosisAnimalsHumansRabbitsFluvastatinFoam CellsLeukocytes, MononuclearMacrophagesCholesterol

Stichwörter der Autor:innen

NLRP3 inflammasomefoam cellsgranulomashost-directed therapymevalonate-kinase deficienciesstatinstuberculosis

Substanzen

FluvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsCholesterol

Autor:innen und Institutionen

  • Servicio de Bioquímica-Investigación, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
  • Servicio de Neurobiología-Investigación, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
  • Servicio de Inmunología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
  • Departamento de Biología Molecular y Celular, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), 28049 Madrid, Spain.
  • Unidad de Cirugía Experimental y Animalario, Investigación, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
  • Servicio Interdepartamental de Investigación (SIdI), Facultad de Medicina, Universidad Autónoma, 28029 Madrid, Spain.

ORCID-Profile: Joaquín Matilla, Rafael Gonzalo-Gobernado, Diego Gómez-Coronado

Förderung

  • Fondo de Investigación Sanitaria
  • Instituto Ramón y Cajal de Investigación Sanitaria
  • Fondo de Investigación Sanitaria, Instituto de Salud Carlos III

Zitieren

APA

Montero-Vega, M. T., Matilla, J., Bazán, E., Reimers, D., De Andrés-Martín, A., Gonzalo-Gobernado, R., Correa, C., Urbano, F., & Gómez-Coronado, D. (2024). Fluvastatin Converts Human Macrophages into Foam Cells with Increased Inflammatory Response to Inactivated Mycobacterium tuberculosis H37Ra. Cells. https://doi.org/10.3390/cells13060536

Vancouver

Montero-Vega MT, Matilla J, Bazán E, Reimers D, De Andrés-Martín A, Gonzalo-Gobernado R, et al. Fluvastatin Converts Human Macrophages into Foam Cells with Increased Inflammatory Response to Inactivated Mycobacterium tuberculosis H37Ra. Cells. 2024. doi:10.3390/cells13060536

BibTeX
@article{MonteroVega2024,
  author = {Montero-Vega, María Teresa and Matilla, Joaquín and Bazán, Eulalia and Reimers, Diana and De Andrés-Martín, Ana and Gonzalo-Gobernado, Rafael and Correa, Carlos and Urbano, Francisco and Gómez-Coronado, Diego},
  title = {Fluvastatin Converts Human Macrophages into Foam Cells with Increased Inflammatory Response to Inactivated Mycobacterium tuberculosis H37Ra},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13060536}
}
Kostenlos starten →